Lucas V A Boersma
Overview
Explore the profile of Lucas V A Boersma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
2159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bochem A, Boersma L, van der Crabben S
Neth Heart J
. 2024 Aug;
32(9):335-336.
PMID: 39150468
No abstract available.
12.
Aarnink E, Maarse M, Boersma L
JACC Cardiovasc Interv
. 2024 Aug;
17(15):1854.
PMID: 39142762
No abstract available.
13.
Aarnink E, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, et al.
Europace
. 2024 Jul;
26(7).
PMID: 39082730
Aims: Sufficient survival time following left atrial appendage occlusion (LAAO) is essential for ensuring the efficacy and cost-effectiveness of this strategy for stroke prevention. Understanding prognostic factors for early mortality...
14.
Aarnink E, Della Rocca D, Cepas-Guillen P, Benito-Gonzalez T, Polzin A, Branca L, et al.
Cardiology
. 2024 Jul;
:1-8.
PMID: 38986462
Introduction: Patients undergoing left atrial appendage occlusion (LAAO) are at increased risk for bleeding or thromboembolic events. Concurrently, biomarkers are of growing importance in risk stratification for atrial fibrillation patients....
15.
Boersma L, Natale A, Haines D, DeLurgio D, Sood N, Marchlinski F, et al.
Heart Rhythm
. 2024 Jun;
PMID: 38925335
Background: Early recurrence of atrial tachyarrhythmias (ERAT) within 3 months of thermal ablation for atrial fibrillation (AF) is common and often considered transient. Pulsed field ablation (PFA) is a nonthermal...
16.
Aarnink E, Maarse M, Fierro N, Mazzone P, Beneduce A, Tondo C, et al.
JACC Cardiovasc Interv
. 2024 May;
17(11):1311-1321.
PMID: 38795093
Background: Left atrial appendage occlusion (LAAO) provides mechanical cardioembolic protection for atrial fibrillation (AF) patients who cannot use oral anticoagulation therapy (OAT). Patients with a thrombotic event despite OAT are...
17.
Knops R, Lloyd M, Roberts P, Wright D, Boersma L, Doshi R, et al.
N Engl J Med
. 2024 May;
391(15):1402-1412.
PMID: 38767244
Background: The subcutaneous implantable cardioverter-defibrillator (ICD) is associated with fewer lead-related complications than a transvenous ICD; however, the subcutaneous ICD cannot provide bradycardia and antitachycardia pacing. Whether a modular pacing-defibrillator...
18.
Swerdlow C, Gillberg J, Boersma L, Manlucu J, Zhang X, Zhang Y, et al.
JACC Clin Electrophysiol
. 2024 May;
10(8):1896-1912.
PMID: 38752961
Background: The extravascular (EV) implantable cardioverter-defibrillator (ICD) includes features to address sensing and arrhythmia detection challenges presented by its substernal lead location. Objectives: In this study, the authors sought to...
19.
van Veelen A, Verstraelen T, Somsen Y, Elias J, van Dongen I, Delnoy P, et al.
J Am Heart Assoc
. 2024 Apr;
13(8):e032033.
PMID: 38591264
Background: Chronic total coronary occlusions (CTO) substantially increase the risk for sudden cardiac death. Among patients with chronic ischemic heart disease at risk for sudden cardiac death, an implantable cardioverter...
20.